Diabetes News Nucleus

The burden of diabetes is expected to increase in India as a result of rapid demographic and lifestyle changes that include the aging population,..

Insulin initiation and titration can be challenging for several clinicians who are involved in the treatment of patients with type 2 diabetes. Mo..

Dipeptidyl peptidase-4 (DPP-4) inhibitors, or gliptins, are a relatively new class of oral drugs for type 2 diabetes. These drugs block the DPP-4..

A close link exists between DM and cardiovascular disease (CVD). CVD is the most prevalent cause of mortality and morbidity in diabetic populatio..

The AACE Annual Meeting was held between May 26 and May 29 this year, while the ADA Scientific Sessions were held virtually from June 25-29.It is..

Diabetes News Nucleus (DNN) news bulletin aims to bring to you all the latest updates in the field of diabetes care from across the world that yo..

About 1 in 10 people with type 2 diabetes could have hypothyroidism. In autoimmune type 1 diabetes, the prevalence of hypothyroidism is 25% or mo..

Through this news bulletin, we aim to bring to you everything that is new in the field of diabetes care from across the world.  In this..

Diabetes News Nucleus is an initiative by Medtalks, in association with Mankind Pharma, to bring to you new findings in the prevention and manage..

Diabetes is caused by chronic high glucose levels in the blood as a result of the incapability of beta cells (β cells) in the pancreas to produc..

Diabetes News Nucleus is an initiative by Medtalks, in association with Mankind Pharma, to bring to you new findings in the prevention and manage..

An initiative by Medtalks, in association with Mankind Pharma to bring to you new findings from key trials, in the prevention and management of d..

This is an initiative by Medtalks, in association with Mankind Pharma. Through this news bulletin, we aim to bring to you everything that is new ..